share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

諾和諾德 | 6-K：諾和諾德-股票回購計劃
美股sec公告 ·  06/25 00:10
牛牛AI助理已提取核心訊息
Novo Nordisk A/S, a leading global healthcare company, has reported progress on its share repurchase program. The company, headquartered in Denmark, initiated the program on May 6, 2024, as part of a larger DKK 20 billion buyback plan set to occur over a 12-month period starting February 6, 2024. As of June 24, 2024, Novo Nordisk has repurchased 1,150,040 B shares under the current program, with a total expenditure of DKK 1,082,466,722. The transactions were made between June 17 and June 21, 2024, with the number of shares purchased each day ranging from 36,000 to 36,500 at average prices between DKK 979.90 and DKK 986.99. Overall, since the beginning of the buyback period in February, the company has acquired 9,884,290 B shares at an average price of DKK 871.10 per share, amounting to a total spend of DKK 8,610,201,494. Novo Nordisk now holds 11,249,854 B shares as treasury shares, which is 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has reported progress on its share repurchase program. The company, headquartered in Denmark, initiated the program on May 6, 2024, as part of a larger DKK 20 billion buyback plan set to occur over a 12-month period starting February 6, 2024. As of June 24, 2024, Novo Nordisk has repurchased 1,150,040 B shares under the current program, with a total expenditure of DKK 1,082,466,722. The transactions were made between June 17 and June 21, 2024, with the number of shares purchased each day ranging from 36,000 to 36,500 at average prices between DKK 979.90 and DKK 986.99. Overall, since the beginning of the buyback period in February, the company has acquired 9,884,290 B shares at an average price of DKK 871.10 per share, amounting to a total spend of DKK 8,610,201,494. Novo Nordisk now holds 11,249,854 B shares as treasury shares, which is 0.3% of the share capital. The company's shares are traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
領先的全球醫療保健企業Novo Nordisk A/S報告了其股票回購計劃的進展情況。這家位於丹麥的公司於2024年5月6日啓動了該計劃，作爲一項總額爲200億丹麥克朗的回購計劃的一部分，該計劃將從2024年2月6日開始，爲期12個月。截至2024年6月24日，Novo Nordisk在當前計劃下回購了1,150,040股B股，總花費爲10.824億丹麥克朗。這些交易發生在2024年6月17日至6月21日之間，每天購買的股票數量在36000到36500之間，平均價格在979.90丹麥克朗和986.99丹麥克朗之間。總體而言，自2月份回購期開始以來，該公司以871.10丹麥克朗的平均價格收購了9,884,290股B股，總花費爲86.102億丹麥克朗。Novo Nordisk現持有11,249,854股B股作爲庫藏股，佔股權的0.3%。該公司的股票在納斯達克哥本哈根交易所上交易，其美國存託憑證在紐約證券交易所上市。
領先的全球醫療保健企業Novo Nordisk A/S報告了其股票回購計劃的進展情況。這家位於丹麥的公司於2024年5月6日啓動了該計劃，作爲一項總額爲200億丹麥克朗的回購計劃的一部分，該計劃將從2024年2月6日開始，爲期12個月。截至2024年6月24日，Novo Nordisk在當前計劃下回購了1,150,040股B股，總花費爲10.824億丹麥克朗。這些交易發生在2024年6月17日至6月21日之間，每天購買的股票數量在36000到36500之間，平均價格在979.90丹麥克朗和986.99丹麥克朗之間。總體而言，自2月份回購期開始以來，該公司以871.10丹麥克朗的平均價格收購了9,884,290股B股，總花費爲86.102億丹麥克朗。Novo Nordisk現持有11,249,854股B股作爲庫藏股，佔股權的0.3%。該公司的股票在納斯達克哥本哈根交易所上交易，其美國存託憑證在紐約證券交易所上市。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。